Bleomycin-associated pulmonary toxicity complicated ABVD, contributed to PCP pneumonia, and impeded regimen completion, ...

Dr. Miranda Gogishvili, a medical oncologist at the High Technology Medical Center, University Clinic in Tbilisi, Georgia, ...

What was once 25 treatments over five weeks can now often be delivered in 16 treatments, or even as few as five fractions.

In a recent interview with CURE, Prentiss emphasized that the current "wait and see" approach to lymphedema is failing ...

Incidence and mortality are rising in cohorts born after the 1950s, with three-quarters of colorectal cancers under 50 diagnosed at advanced stage, limiting curability. Preventable mortality is ...

Candidate profiles include HCC, liver metastases, and hepatic adenomas, including multifocal disease and stage IV patients who might otherwise be excluded from liver-directed interventions. Outpatient ...

Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024.

Nuvalent seeks FDA approval of neladalkib for TKI-pretreated advanced ALK-positive NSCLC, leveraging ALKOVE-1 results demonstrating activity in extracranial disease and brain metastases. ALKOVE-1 ...

Discover how modern immunotherapy awakens T cells to shrink melanoma tumors, tracked by PET scans and used after surgery to prevent relapse. In this segment, Dr. Morrison provides clinical context ...

Expanding local access to clinical trials improves options by reducing barriers and bringing research opportunities closer to ...

Breast Cancer Briefing, hosted by Dr. Sara Nunnery, a breast medical oncologist and the director of Breast Cancer Research at ...

The U.S. Food and Drug Administration (FDA) has granted traditional full approval to the CAR-T cell therapy Tecartus ...